Medical device firm Therox files for $100 mln IPO

WASHINGTON, Sept 4 (Reuters) - Therox Inc, a medical device company focused on treating oxygen deprived tissue, said on Thursday it is planning an initial public offering of as much as $100 million in common stock.

Citi, UBS Investment Bank, Cowen and Company, and Wachovia Securities will underwrite the IPO, according to a preliminary offering document filed with the Securities and Exchange Commission.

The company is seeking a Nasdaq listing under the symbol "THER." (Editing by Andre Grenon)